Click to goto CDHA Public Site Click to goto DivEMS Dal Public Site Click to goto EHS Nova Scotia

Pediatric Tachycardia

Date Last Search Run: Feb 01, 2022
Table last updated: May 02, 2021
Data last added: Apr 30, 2019

Recommendation RECOMMENDATION FOR INTERVENTION
STRENGTH OF EVIDENCE FOR INTERVENTION   SUPPORTIVE (Green) NEUTRAL (Yellow) AGAINST (Red) NOT YET GRADED (White)
1 (strong evidence exists)      
2 (fair evidence exists)    
3 (weak evidence exists)


Interventions

Adenosine
Level Direction Primary Outcome Patient/Process Setting Reference
III Supportive (Green) Successful cardioversion Patient ED-MD Losek J., Endom E., Dietrich A., et al. Adenosine and pediatric supraventricular tachycardia in the emergency department: Multicenter study and review. Anns Emerg Med 1999; 33:185-99. Medline
III Supportive (Green) Conversion Patient ED-MD Overholt E., Rheuban K., Gutgesell H., et al. Usefulness of adenosine for arrhythmias in infants and children. Am J Cardiol 1988; 61:336-40. Medline

Amiodarone
Level Direction Primary Outcome Patient/Process Setting Reference
III Supportive (Green) Conversion Patient ED-MD Perry J., Fenrich A., Hulse E., et al. Pediatric use of intravenous amiodarone: Efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol 1996; 27:1246-50. Medline
III Supportive (Green) Conversion Patient ED-MD Perry J., Knilans T., Marlow D., et al. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. J Am Coll Cardiol 1993; 22:95-8. Medline

Digoxin
Level Direction Primary Outcome Patient/Process Setting Reference
III Neutral (Yellow) Time to conversion Process ED-MD Sreeram N., Wren C. Supraventricular tachycardia in infants: response to initial treatment. Archives of Disease in Childhood 1990; 65:127-129. Medline

Electrical Cardioversion
Level Direction Primary Outcome Patient/Process Setting Reference
III Supportive (Green) Conversion Patient ICU Sreeram N., Wren C. Supraventricular tachycardia in infants: response to initial treatment. Archives of Disease in Childhood 1990; 65:127-129. Medline

Lidocaine
Level Direction Primary Outcome Patient/Process Setting Reference

Vagal Maneuver / ice water
Level Direction Primary Outcome Patient/Process Setting Reference
II Supportive (Green) Arrhythmia termination (determined by pulse) Patient Bronzetti G., Brighenti M., Mariucci E., Fabi M., Lanari M., Bonvicini M., et al. Upside-down position for the out of hospital management of children with supraventricular tachycardia. Int J Cardiol 2018;252:106-9. Medline
III Supportive (Green) Conversion Patient ICU Sreeram N., Wren C. Supraventricular tachycardia in infants: response to initial treatment. Archives of Disease in Childhood 1990; 65:127-129. Medline

Verapamil
Level Direction Primary Outcome Patient/Process Setting Reference
III Neutral (Yellow) Conversion Patient ICU Sreeram N., Wren C. Supraventricular tachycardia in infants: response to initial treatment. Archives of Disease in Childhood 1990; 65:127-129. Medline
III Opposes (Red) Conversion Patient ED-MD Epstein M., Kiel E., Victorica B. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 1985; 75:737-40. Medline
III Opposes (Red) Conversion Patient ED-MD Kirk C., Gibbs J., Thomas R., et al. Cardiovascular collapse after verapamil in supraventricular tachycardia. Archives of Disease in Childhood 1987; 62:1265-82. Medline


[ PEP Database - Table of Contents ] [ Email: PEP@Dal.ca ]